FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to otorhinolaryngology, and may be used in conducting the antiviral therapy in treating antiviral and hyperplastic nasopharyngeal diseases in children. That is ensured by prescribing cyclopheron in the period of acute clinical manifestations in a clinically effective daily doses prescribed considering patient's weight and age in the five- or ten-day therapeutic course in a combination with the local administration of 20% aqueous sulphacyl sodium 2-3 drops in both nostrils with patient's head lag 3 times a day in the ten-day therapeutic course. Cyclopheron is prescribed in rarely ill patients suffering ARVIs in the five-day therapeutic courses. In recurrently ill patients and in the setting of hyperplastic nasopharyngeal conditions, in chronic nasopharyngitis, chronic adenoiditis and pharyngeal lymphoid tissue ring hyperplasia, the patient undergoes the ten-day therapeutic course in each aggravation of clinical manifestations to reduce the rate of acute clinical manifestation and stable clinical remission. Local sanitation of the inflammation centre with sulphacyl sodium in all cases is performed within the ten-day therapeutic courses.
EFFECT: invention enables reducing the length and rate of the aggravations of inflammatory and hyperplastic nasopharyngeal diseases in children.
3 ex
